Isabelle Martel‐Lafay

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial

Thierry Conroy, Marie‐Pierre Galais, Jean‐Luc Raoul et al. · The Lancet Oncology · 2014 · 446 citations

Medicine, Oncology, Radiation Oncology +15

Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer

Jean‐Pierre Gérard, D. Azria, S. Gourgou-Bourgade et al. · Journal of Clinical Oncology · 2012 · 432 citations · Full text

Medicine, Oncology, Surgery +17

Early Variations of Circulating Interleukin-6 and Interleukin-10 Levels During Thoracic Radiotherapy Are Predictive for Radiation Pneumonitis

D. Arpin, David Pérol, Jean‐Yves Blay et al. · Journal of Clinical Oncology · 2005 · 148 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity

Adeline Granzotto, Mohamed Amine Benadjaoud, Guillaume Vogin et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 122 citations

Medicine, Molecular Biology, Oncology +17

Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer

D. Azria, J. Doyen, Marta Jarlier et al. · Annals of Oncology · 2017 · 106 citations · Full text

Medicine, Oncology, Radiation Oncology +15